Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

PHASE4RecruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions

Respiratory Tract InfectionsInfectionsAllergyEczema

Interventions

BIOLOGICAL

Measles-Mumps-Rubella vaccine (MMR)

0.5 ml of MMR vaccine injected intramuscularly in the deltoid region or in the anterolateral area of the thigh

Trial Locations (1)

RECRUITING

University Hospitals of Geneva, Geneva

All Listed Sponsors

lead

Laure Pittet, MD-PhD

OTHER